Choose language:
Announcements for the Copenhagen Stock Exchange in 2007
20 December 2007 (No. 38-07)
Bavarian Nordic Receives USD 25 Million Milestone Payment from the U.S. Government for Fulfilling Contract Milestones
12 December 2007 (No. 37-07)
Bavarian Nordic A/S issues Financial Calendar for 2008
30 November 2007 (No. 36-07)
Bavarian Nordic A/S announces change in group management
29 November 2007 (No. 35-07)
Bavarian Nordic Receives USD 25 Million Milestone Payment from the U.S. Government for Fulfilling Contract Milestones
29 November 2007 (No. 34-07)
Bavarian Nordic A/S reports positive data from first EUA enabling study with IMVAMUNE® smallpox vaccine
6 November 2007 (No. 33-07)
Bavarian Nordic A/S – Interim Report for the period 1 January to 30 September 2007
8 October 2007 (No. 32-07)
Bavarian Nordic Receives USD 50 Million Advance Payment from the U.S. Government for Fulfilling Contract Milestones
4 October 2007 (No. 31-07)
Bavarian Nordic appoints Nicolai Buhl Andersen as Executive Vice President, Commercial Affairs
3 October 2007 (No. 30-07)
U.S. government extends RFP-2 contract with Bavarian Nordic
19 September 2007 (No. 29-07)
Bavarian Nordic Strengthens its Commercial Organisation and Updates on Pipeline Progress
9 August 2007 (No. 28-07)
Bavarian Nordic A/S – Interim Report for the period 1 January to 30 June 2007
26 July 2007 (No. 27-07)
Bavarian Nordic and Acambis settle all legal disputes on MVA
13 July 2007 (No. 26-07)
Anders Hedegaard will take up position as President & CEO of Bavarian Nordic on 1 August 2007
25 June 2007 (No. 25-07)
Bavarian Nordic Appeals Austrian Court Ruling on Non-Infringement
7 June 2007 (No. 24-07)
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such
4 June 2007 (No. 23-07)
U.S. Department of Health and Human Services awards an exclusive contract to Bavarian Nordic for the delivery of 20 million doses of IMVAMUNE®. Financial guidance for 2007 is raised with DKK 300 million.
1 June 2007 (No. 22-07)
Bavarian Nordic A/S - total number of voting rights and size of share capital in as of 1 June 2007
16 May 2007 (No. 21-07)
Bavarian Nordic Appeals Delaware Order Dismissing Claims Related To Acambis’ Misuse of Viral Sample
15 May 2007 (No. 20-07)
Bavarian Nordic A/S – Report on the Results of the Extraordinary General Meeting, held 15 May 2007
3 May 2007 (No. 19-07)
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such
2 May 2007 (No. 18-07)
Bavarian Nordic A/S increases its share capital as a consequence of exercise of warrants
27 April 2007 (No. 17-07)
Bavarian Nordic A/S – Notice convening extraordinary general meeting
26 April 2007 (No. 16-07)
Bavarian Nordic A/S – Report on the Results of the Annual General Meeting, held 26 April 2007
26 April 2007 (No. 15-07)
Bavarian Nordic A/S – Interim Report as of 31 March 2007
19 April 2007 (No. 14-07)
Anders Hedegaard appointed new CEO of Bavarian Nordic. Peter Wulff stays on in Corporate Management as Head of Business Development
16 April 2007 (No. 13-07)
U.S. Government Notifies Bavarian Nordic of Intent to Acquire 20 Million Doses of IMVAMUNE® Smallpox Vaccine
3 April 2007 (No. 12-07)
Bavarian Nordic A/S – Notice convening ordinary general meeting
30 March 2007 (No. 11-07)
Bavarian Nordic A/S – Annual Results 2006
28 March 2007 (No. 10-07)
Bavarian Nordic A/S completes fully subscribed rights issue
23 March 2007 (No. 09-07)
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such
22 March 2007 (No. 08-07)
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such
20 March 2007 (No. 07-07)
Bavarian Nordic A/S Issues Revised Financial Calendar
8 March 2007 (No. 06-07)
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such
22 February 2007 (No. 05-07)
U.S. International Trade Commission Refers MVA Case Back to the Administrative Law Judge
20 February 2007 (No. 04-07)
Bavarian Nordic A/S publishes prospectus for rights issue
2 February 2007 (No. 03-07)
Bavarian Nordic and GSK to terminate collaboration
22 January 2007 (No. 02-07)
U.S. International Trade Commission requests additional briefing relating to remedy
3 January 2007 (No. 01-07)
Bavarian Nordic A/S receives approval to start Phase I/II trials with breast cancer vaccine
Home | Sitemap | Disclaimer | Privacy Contact us